Liver Biopsy in Chronic Liver Diseases: Is There a Favorable Benefit: Risk Balance?

Journal Title: Annals of Hepatology - Year 2017, Vol 16, Issue 4

Abstract

Liver biopsy is still useful in selected clinical situations in which it is the only tool to obtain information necessary for the diagnosis, the prognosis, and the decision for treatment. Main examples are viral hepatitis with confounding co-morbidities, non alcoholic fatty liver disease, and autoimmune liver diseases.

Authors and Affiliations

Dominique Larrey, Lucy Meunier, José Ursic-Bedoya

Keywords

Related Articles

Model for end stage of liver disease (MELD) is better than the Child-Pugh score for predicting in-hospital mortality related to esophageal variceal bleeding

Aim: The Child Pugh and MELD are good methods for predicting mortality in patients with chronic liver disease. We investigated their performance as risk factors for failure to control bleeding, in-hospital overall mortal...

Graft calcification caused by a torsion of the hepatic vein after a living-related donor liver transplantation

The torsion of vessels after liver transplantation rarely occurs. Likewise, calcification of a liver graft has seldom been reported. This report details a case which had torsion of the left hepatic vein on the seventh d...

Potential Molecular Targets of Statins in the Prevention of Hepatocarcinogenesis

Hepatocellular carcinoma (HCC) represents 90% of liver tumors. Statins, may reduce the incidence of various tumors, including HCC. Antitumoral activities may be mediated by changes in transforming growth factor-beta (TGF...

The effect of celecoxib on the development of diethylnitrosamine-induced liver tumors in rats

[b]Background/aims[/b]. Hepatocellular carcinoma is one of the most commonly diagnosed malignant tumors in the world, and it typically has a poor prognosis. Extensive studies have examined the effects of non-steroidalant...

Download PDF file
  • EP ID EP189413
  • DOI 10.5604/01.3001.0010.0272
  • Views 100
  • Downloads 0

How To Cite

Dominique Larrey, Lucy Meunier, José Ursic-Bedoya (2017). Liver Biopsy in Chronic Liver Diseases: Is There a Favorable Benefit: Risk Balance?. Annals of Hepatology, 16(4), 487-489. https://europub.co.uk./articles/-A-189413